Skip to content
Home
Our Science
Pipeline & Assets
Team & Investors
Careers
News & Resources
Connect
News
& Resources
Featured Stories
Siren Biotechnology to Showcase Clinical-Stage Momentum at Major 2026 Healthcare Conferences
Read More
Pepperdine Graziadio Business School
Siren Biotechnology named a 2025 Most Fundable Company
Read More
Siren Biotechnology Opens Community Investment Round!
Read More
Press Release
Siren Biotechnology Expands Clinical and Scientific Advisory Board with Key Industry Leaders
Read More
News
Patient Resources
Videos
Publications & Presentations
All
Media Coverage
Press Releases
Press Releases
|
Posted on 5.17.23
Siren Biotechnology Launches to Pioneer Universal AAV Immuno-Gene Therapy for Cancer
Read More
Media Coverage
|
Posted on 3.2.23
Nicole Paulk is named one of the Bay Area’s next generation of life science researchers
Read More
Media Coverage
|
Posted on 12.5.22
Insights from Nicole Paulk on the latest gene therapy for hemophilia B
Read More
Media Coverage
|
Posted on 8.25.22
Siren’s Founder & CEO, Nicole Paulk, speaks on pricing and access for gene therapies
Read More
Media Coverage
|
Posted on 10.1.21
Hear from Nicole Paulk on XLMTM gene therapy
Read More
Media Coverage
|
Posted on 8.12.21
Nicole Paulk on gene therapy’s next steps
Read More
Media Coverage
|
Posted on 5.17.21
Beyond AAV 1.0 – Nicole Paulk discusses breaking down barriers for the future of AAV
Read More
1
…
3
4
5
